| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.36 | 0.03 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.098 | 0.03 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.04 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |